Utah Medical Products INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Brandes Investment Partners, L.P. and Datum One Series Trust have disclosed a combined beneficial ownership of 14.9% in Utah Medical Products, Inc., signaling a substantial investment position.
NASDAQ
Brandes Investment Partners, L.P. has filed an amended Schedule 13G reporting a 14.12% beneficial ownership stake in Utah Medical Products, Inc.
NASDAQ
The Vanguard Group reports 0% beneficial ownership in Utah Medical Products Inc. common stock following an internal realignment.
NASDAQ
Brandes Investment Partners, L.P. has reported a 10.4% beneficial ownership stake in Utah Medical Products Inc., holding 333,204 common shares.
NASDAQ
Brandes Investment Partners, L.P. has disclosed a 7.39% beneficial ownership stake in Utah Medical Products Inc. common shares.
NASDAQ
BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.3% of Utah Medical Products Inc.'s common stock as of June 30, 2025.
NASDAQ
Dimensional Fund Advisors LP has filed an amended Schedule 13G, reporting a 6.1% beneficial ownership stake in Utah Medical Products Inc. common stock as of June 30, 2025.
NASDAQ
Brandes Investment Partners, L.P. has filed a Schedule 13G, reporting beneficial ownership of 242,421 common shares, representing 7.4% of Utah Medical Products Inc.
NASDAQ
BlackRock, Inc. has filed an updated Schedule 13G, reporting a 4.97% beneficial ownership stake in Utah Medical Products Inc. as of December 31, 2024, held for ordinary course of business purposes.
NASDAQ
SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 2.7% Passive Stake in Utah Medical Products Inc.
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.7% in Utah Medical Products Inc. as of December 31, 2024.